BTG plc (BTG.L): Varisolve® NDA Accepted for Full Review by FDA
4/12/2013 10:59:16 AM
More...
|
BTG plc (BTG.L): Close Period Update
4/4/2013 9:49:29 AM
More...
|
BTG plc (BTG.L): Varisolve® NDA Submitted to the FDA
2/4/2013 1:04:07 PM
More...
|
Centers for Medicare & Medicaid Services Grants New Prospective Reimbursement for BTG plc (BGC.L)'s Voraxaze®
9/5/2012 10:57:16 AM
More...
|
AstraZeneca PLC (AZN), BTG plc (BGC.L) Scrap Sepsis Drug as Trial Fails
8/8/2012 7:27:52 AM
More...
|
Clinigen Appointed by BTG plc (BGC.L) to Manage Named-Patient Programs for DigiFab(r) and Voraxaze(r) in Certain Territories Outside the US
6/1/2012 11:14:21 AM
More...
|
Wellstat Therapeutics Corporation Grants BTG plc (BGC.L) European Distribution Rights to Investigational Antidote for 5-FU Overexposure
5/22/2012 12:20:31 PM
More...
|
BTG plc (BGC.L) Release: Voraxaze(R) (glucarpidase) Launched in the US
4/30/2012 11:18:29 AM
More...
|
BTG plc (BGC.L)'s Varicose-vein Drug Succeeds in US Study
1/30/2012 8:01:56 AM
More...
|
FDA Approves BTG plc (BGC.L)'s Drug for Cancer Toxicity
1/18/2012 7:43:03 AM
More...
|
|